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ABSTRACT
The aim of this article is to characterize the biological aspects of oral strains of C. albicans in children with 
Down’s syndrome. These yeasts were analyzed as to their macromorphological and enzymatic aspects and 
were tested as to their in vitro susceptibility to antifungal drugs using broth microdilution to determine the 
minimum inhibitory concentration (MIC). The morphotyping revealed that all oral C. albicans isolates 
from children with Down’s syndrome promoted the formation of fringes regardless of size, while the 
control group presented smaller fringes. All oral C. albicans strains produced proteinase, but those with 
phospholipolytic activity showed greater enzyme capacity in the test group. In vitro susceptibility showed 
that all oral C. albicans isolates were sensitive to the drugs used. 
Keywords: Phenotyping, Candida albicans, Down’s syndrome.
RESUMO
Aspectos fenotípicos de cepas de Candida albicans orais em crianças com síndrome de down
O objetivo deste artigo foi caracterizar os aspectos biológicos de cepas de C. albicans orais em crianças 
com síndrome de Down. Estas leveduras foram analisadas quanto aos seus aspectos macromorfológicos 
e enzimáticos e foram testadas quanto a sua suscetibilidade in vitro a drogas antifúngicas, usando a 
microdiluição em caldo para a determinação da concentração inibitória mínima (CIM). A morfotipagem 
revelou que todos os isolados de C. albicans orais de crianças com síndrome de Down induziram à 
formação de franjas independente do tamanho, enquanto o grupo controle teve franjas menores. Todas as 
cepas de C. albicans orais produziram proteinase, mas aquelas com atividade fosfolipidolítica mostraram 
maior capacidade enzimática no grupo teste. A suscetibilidade in vitro mostrou que todos os isolados de C. 
albicans orais foram sensíveis a drogas empregadas.
Palavras-chave: fenotipagem, Candida albicans, síndrome de Down.
INTRODUCTION
The mouth is one of the most diversified 
sources of microorganisms, where yeasts of the 
genus Candida play a relevant role due to their 
presence from the initial development of the oral 
microbiota to the definitive one (Marcantoni, 1999). 
In children with Down’s syndrome, pathoanatomical 
disorders predispose them to the proliferation of 
Candida strains, completely populating the floor of 
the mouth with this yeast-like fungus, which often 
causes candidiasis (Campos, 2001).
The onset of the infectious process by 
Candida in the mouth of children with Down’s syn-
drome, in addition to abnormal innate and acquired 
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immunological conditions, is also influenced by the 
pathogenic capacity of these yeasts, initially acting 
as colonizers and later on as infectious agents due 
to the alteration of the oral microbiota produced 
by microbiological, chemical and physical factors, 
such as chewing and/or poor mouth cleaning 
(Campos, 2001; Ribeiro et al., 2002). 
The methods for typing Candida cultures 
have been used to better characterize the biological 
aspects presented by these yeasts. Therefore, the 
phenotypic characterization of yeast-like fungi 
enables us to assess macroscopically how these 
microorganisms behave as a constituent part of 
the topical microbiota and/or as the triggering 
mechanism of candidiasis regarding morphological, 
serological, biological, and antifungal parameters 
(Prince et al., 1982; ghannoum & Abu-Elteen, 1990; 
Odds, 1998; Cândido et al., 2000; Pinto, 2003). 
The aim of this article is to establish 
the phenotypic profile of oral Candida yeasts 
in children with Down’s syndrome given the 
morphotyping of fringes and the fungal topography 
of colonies, production of exoenzymes (proteinase 
and phospholipase) and antifungaltyping.
MATERIAL AND METHODS
Strains of C. albicans
The 35 strains of C. albicans used in this 
work were due to a case-control study involving 
oral yeasts of Candida isolated from children with 
and without trisomy of the 21st chromosome. There 
were twenty five (25/30) (83.3%) oral strains of 
C. albicans from children with Down’s syndrome 
and ten (10/60) (16.7%) from the control group 
(children without the syndrome) treated at the 
Pediatric Dental Clinic of the School of Dentistry 
at the universidade Federal de goiás (CO/FO/
uFg) in goiânia, state of goiás, brazil. The yeasts 
used in this study were isolated and identified 
according to kreegen-van Rij (1984). These strains 
of C. albicans were obtained from individuals 
between 0 and 10 years old with an intact oral 
mucosa and who were not on any type of drug 
therapy. The present study was previously accepted 
by the Committee of Ethics in the Human Medical 
Investigation and Animal of the Clinics Hospital at 
the universidade Federal de goiás (HC/uFg) and 
the parents or guardians of the children gave their 
consent to the investigators.
Phenotyping
Morphological, enzyme and antifungal 
phenotyping used in the present study aims 
at establishing an epidemiological correlation 
between the Candida strains analyzed herein.
Morphotyping
A phenotypic marker was detected in malt 
extract agar with the seeding of two strains of 
Candida (inoculum with turbidity adjusted in 
3 on Mc Farland scale) on each Petri dish with 
sterilized swabs. After the incubation of the dishes 
at 25 °C for 10 days, the reading was based on the 
macromorphological aspects of the fringes and on 
the topography of the colony by way of the model 
proposed by Hunter et al. (1989) (Table 1). 
Enzymetyping 
The production of extracellular enzymes by 
Candida species was detected for proteinase in a 
basic medium enriched with albumin and vitamins 
(Rüchel et al., 1982) and for phospholipase in 
Sabouraud dextrose agar (SDA) and egg yolk (Prince 
et al., 1982). After incubation in a greenhouse 
at 37 °C for 48 h for proteinase and for 96 h for 
phospholipase, the reading of test isolates and of 
the standard strain (Candida albicans CbS 562) 
granted by the mycological collection of the Institute 
of biomedical Sciences at the universidade de São 
Paulo (ICb/uSP), brazil was performed based on 
the production of the precipitation zone around the 
inoculation point of Candida isolates. The enzyme 
activity (P
z
) resulted from the relation between the 
diameter of the colony (dc) and the diameter of the 
colony and precipitation zone (dcp). The results 
were classified as negative (Pz = 1 cm), positive 
(0.64 cm ≥ Pz < 1 cm) and strongly positive 
(Pz < 0.64 cm).
Antifungaltyping 
The in vitro susceptibility test was carried 
out by broth microdilution, standardized by the 
National Committee for Clinical Laboratory 
Standards (NCCLS) (Atlanta, uSA) to de-
termine the minimum inhibitory concentration 
(MIC). Amphotericin b and 5–fluorocytosine 
were obtained from Sigma Chemical Company. 
Fluconazole and itraconazole were used in their 
commercial formulation available in brazil: 
150 mg and 100 mg respectively. To prepare 
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the standard solution, 5 mg of each drug were 
weighed, yielding concentrations of 640 µg/mL and 
1280 µg/mL for amphotericin b and itraconazole, 
respectively, which were solubilized in dimethyl 
sulfoxide (DMSO) at the concentration of 1% of 
the volume of the standard solution. both water-
soluble fluconazole and 5–fluorocytosine yielded 
concentrations of 1.250 µg/mL and 1.000 µg/mL, 
respectively. From these solutions, serial dilutions 
of the drugs were prepared in MOPS (morpho-
linepropanesulfonic acid)-buffered RPMI-1640 
(pH 7.0) in order to obtain the desired concentra-
tions of antifungals. The following concentrations 
were used: 0.02 at 16.0 µg/mL for amphotericin 
b, 0.012 at 12.5 µg/mL for 5-fluorocytosine, 
0.04 at 32.0 µg/mL for itraconazole and 0.08 at 
64.0 µg/mL for fluconazole. 
The inoculum of Candida strains was grown 
in Sabouraud dextrose agar (SDA) for 48 h at 35 °C. 
This solution was prepared in 5 mL of deionized 
and sterilized water and the cellular density was 
adjusted on a spectrophotometer for an 85% 
transmittance reading in the 530 nm wavelength, 
resulting in a solution with one inoculum between 
0.5 x 102 and 2.5 x 103 CFu/mL (colony forming 
units per milliliter).
Covered acrylic dishes were used for 
microdilution, with 96 wells (Difco, Detroit, uSA). 
Each well received 100 µg/mL of the antifungal drug 
concentration and 100 µg/mL of the test suspension 
of Candida strain. The dishes were incubated at 37 
°C for 48 h. The MIC for azole drugs was defined 
as the first well with a 50% reduction in yeast 
cell growth, comparatively to the positive control 
(drug-free medium). For amphotericin b and 5-
fluorocytosine, the MIC was defined as the lowest 
concentration able to inhibit any visible growth. 
RESULTS
Morphotyping
 The morphotyping of 35 C. albicans strains 
from the oral mucosa of children with and without 
Down’s syndrome enabled us to detect nine 
different morphotypes; the test group (children 
with Down’s syndrome) showed a predominance 
of morphotype 5530 (colony with continuous 
fanlike fringes, equal to or greater than 6 mm, with 
TABLE 1 
Model proposed by Hunter et al. (1989). 
Order of the digits Values
1º Fringe - Distribution  Absent 0
 Discontinuous (≤ 20% of margin) 1
 Discontinuous (20 a 50% of margin) 2
 Discontinuous (60 a 90% of margin) 3
 Continuous at periphery only, or strands conspicuously  fan-shaped 5
 Continuous: filamentous outgrowths uniformly parallel 7
2º Fringe - Width  Absent 0
 2 mm or less 2
 3-5 mm 3
 greater than 6 mm 5
3º Fringe - Texture  Absent 0










 Crateriform plus wrinkles or folds 5
 Wrinkles or folds 6
 Hairy 8
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an intermediate texture and smooth topographical 
aspect). In the group of children without Down’s 
syndrome, a higher incidence of morphotype 5240 
(colony with continuous fanlike fringes, equal 
to or greater than 2 mm, fine texture and smooth 
topographical aspect) was observed (Table 2).
Enzymetyping
Proteinase production was detected in all 
oral strains of C. albicans obtained from the 
mouth of children with and without Down’s 
syndrome, whereas the test group (children with 
Down’s syndrome) was highly proteolytic. As for 
phospholipase, 88.0% (22/25) of oral C. albicans 
strains in the group of children with Down’s 
syndrome produced this exoenzyme in remarkable 
amounts, while in the group of children without 
the syndrome, only 80.0% (8/10) of the oral strains 
showed enzymatic capacity (Table 3).
Antifungaltyping
All oral strains of C. albicans in the test 
and control groups (children with and without 
Down’s syndrome) revealed in vitro sensitivity to 
the antifungal drugs used in broth microdilution 
(Table 4).
DISCUSSION
A deeper understanding concerning the 
phenotypic behavior of Candida cultures analysing 
each sample, either as colonizer and/or pathogen, 
enables us to evaluate the biological diversity 
of existing strains and how such characteristics 
express themselves in the sequencing of the fungal 
process. Yeast-like aspects of Candida observed 
in genotypic characteristics through molecular 
biology by way of one-dimensional electrophoretic 
karyotyping and pulsed field electrophoresis with 
DNA probes, polymerase chain reaction (PCR), or 
also the combination of these techniques enables 
us to differentiate phenotypically undistinguishable 
strains, finding the genetic mapping sequence of 
these yeasts and showing the phenotypic aspect of 
each gene of the fungus (Fukazawa et al., 1997; 
Radford et al., 1997; López-Ribot et al., 2000; 
Melo et al., 2003). 
 The morphological aspect of C. albicans 
colonies showed that the predominance of a smooth 
surface does not depend on the analyzed group 
(children with and without Down’s syndrome). As 
for the disposition of the colonies in fringes, 84.0% 
(21/25) of the strains isolated from the oral mucosa 
of children with Down’s syndrome revealed fringes 
throughout the periphery of the fungal colony, 
whose length was greater than or equal to 6 mm in 
48.0% (12/25) of the strains, and rough structure 
in 68.0% (17/25). Concerning the control group 
(children without the syndrome), fringes were 
present in 80.0% (8/10) of C. albicans strains on 
the entire colony surface, but with a length shorter 
than 5 mm in all strains and rough texture in 
approximately 60.0% (6/10) of the fringes. This 
phenotypic aspect thus showed that the adherence 
capacity of oral strains of C. albicans in the test 
TABLE 2 
Morphotypes observed in C. albicans strains isolated from the mouth of children with and without Down’s syndrome, 
treated at the Pediatric Dental Clinic of the School of Dentistry of Universidade Federal de Goiás, 
Goiânia (GO)/Brazil, 2005.
 Morphotypes Children with Down’s syndrome
n (%)
Children without Down’s syndrome
n (%)
2,330 - 02 (20.00)
3,240 02 (8.00) -
3,340 02 (8.00) -
5,240 - 04 (40.00)
5,320 02 (8.00) 02 (20.00)
5,330 05 (20.00) 02 (20.00)
5,340 02 (8.00) -
5,530 10 (40.00) -
5,540 02 (8.00) -
Total 25 (100.00) 10 (100.00)
Model proposed by Hunter et al. (1989).
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group (children with Down’s syndrome) is more 
exacerbated in vitro than in the control group, 
although all these yeasts are of colonizing type and 
originate from the oral mucosa of children with 
or without this chromosome disorder. Therefore, 
the presence of fringes in yeasts of Candida 
obtained from the mouth is possibly attributed to 
the virulence of this fungus, thus showing a higher 
tendency towards the development of the mycelial 
form by the yeast and favoring the adaptation to the 
oral cavity (Melhem, 1997; Radford et al., 1997; 
Melo et al., 2003). Patients with neoplasms or with 
AIDS have shown oral morphotypes of C. albicans 
with fringes more often than those obtained from 
the mouth of healthy individuals, which reinforces 
its association with yeast virulence (Melhem, 
1997). 
The production of extracellular enzymes by 
Candida yeasts is another capacity that this fungus 
has to establish itself as a colonizing and/or infec-
tious microorganism in man. Proteinase favors the 
adherence of Candida isolates to the surface of in-
fected mucosa due to the penetration of germ tubes 
into the infected tissue (Odds, 1998). However, phos-
pholipase induces the control of fungal growth by its 
presence in the extremities and destruction of lipids 
that constitute the cell membrane (Ribeiro et al., 
2002). Approximately 96.0% (24/25) of oral strains 
of C. albicans from children with Down’s syndrome 
were highly proteolytic, produced phospholipase 
and were highly phospholipidolytic, while 80.0% 
(8/10) of the yeasts in the control group (children 
with Down’s syndrome) showed to produce both en-
zymes. Nevertheless, the individual analysis of the 
productive enzyme capacity of each strain of C. al-
bicans revealed that strains from the mouth of chil-
dren with Down’s syndrome showed enhanced pro-
duction. Cândido et al. (2000) studied 79 Candida 
strains isolated from the mouth of patients with le-
sions characteristic of candidiasis and from individ-
uals with clinically normal oral cavity treated at the 
School of Dentistry in Ribeirão Preto, universidade 
de São Paulo (FO/RP/uSP), brazil, and found out 
that 83.3% and 66.7% of C. albicans strains from 
TABLE 3 
Production of proteinase and phospholipase by oral strains of C. albicans in children with and without Down’s syndrome, 
treated at the Pediatric Dental Clinic of the School of Dentistry of Universidade Federal de Goiás, 
Goiânia (GO)/Brazil, 2005.
Proteinase* Phospholipase*
Children Pz = 1 (%) (0.64 ≥ Pz < 1) (Pz < 0.64) Pz = 1 (%) (0.64 ≥ Pz < 1) (Pz < 0.64)
w/ Down’s 
syndrome
- 01 (4.0) 24 (96.0) 01 (4.0) 02 (8.0) 22 (88.0)
w/o Down’s 
syndrome
- 06 (60.0) 04 (40.0) 02 (20.0) - 08 (80.0)
Total - 07 (20.0) 28 (80.0) 03 (8.6) 02 (5.7) 30 (85.7)
*(Pz = 1 cm) negative;
 (0.64 cm ≥ Pz < 1 cm) positive; and
 (Pz < 0.64 cm) strongly positive.
TABLE 4 
Minimum inhibitory concentration (MIC) of antifungals in relation to the C. albicans strains isolated from the mouth of 
children treated at the Pediatric Dental Clinic of the School of Dentistry of Universidade Federal de Goiás, Brazil, 2005.
Antifungals
MIC
Children w/ Down’s syndrome Children w/o Down’s syndrome
MIC threshold (µg/mL) CI50 (µg/mL) MIC threshold (µg/mL) CI50 (µg/mL)
Amphotericin b 0.08 - 1.00 0.25 0.04 - 1.00 0.25
Fluconazole 0.25 - 4.00 1.00 0.50 - 4.00 2.00
Itraconazole 0.08 - 1.00 0.50 0.04 - 1.00 0.50
5-fluorocytosine 0.024 - 1.56 0.39 0.049 - 1.56 0.39
MIC – minimum inhibitory concentration; and
CI50 – concentration of the drug able to inhibit the growth of C. albicans strains by 50%.
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oral lesions produced phospholipase and proteinase, 
respectively. However, the strains of this yeast ob-
tained from the mouth of individuals with no lesions 
produced phospholipase in 71.9% and proteinase in 
68.7% of the cases. Among the strains of C. albicans 
in both groups, enzymetype 22 (positive phospholi-
pase and weakly positive proteinase) was the most 
prevalent. This showed that the phospholipidolytic 
capacity of oral strains of C. albicans is a prepon-
derating factor for candidiasis (Cândido et al., 2000; 
Ribeiro et al., 2002). ghannoum & Abu-Elteen 
(1990) and Cândido et al. (2000) affirm that these 
hydrolytic enzymes produced by Candida yeasts are 
virulence factors for this yeast-like fungus. 
In vitro tests for sensitivity of oral yeasts of 
C. albicans in children with or without Down’s 
syndrome regarding the antifungal agents used 
(amphotericin b, 5-fluorocytosine, fluconazole 
and itraconazole) showed to be susceptible to all 
antifungals. The strains of C. albicans obtained 
from the mouth of children with this chromosome 
disorder revealed a CI50 (concentration index 
able to inhibit 50% of the strains) equal to 
0.25 µg/mL for amphotericin b, CI50 = 0.39 µg/mL 
for 5-flourocytosine, IC50 = 1.00 µg/mL for flu-
conazole and IC50 = 0.50 µg/mL for itraconazole. 
The control group (children without Down’s 
syndrome) showed a CI50 = 0.25 µg/mL for 
amphotericin b, CI50 = 0.39 µg/mL for 5-fluorocy-
tosine, CI50 = 2.00 µg/mL for fluconazole and 
CI50 = 0.50 µg/mL for itraconazole. batista et al. 
(1999) observed the susceptibility of 19 strains of 
C. albicans, isolated from patients with protein-
induced stomatitis, and found that polyene antibiotics 
had a lower minimal inhibitory concentration than 
azole derivatives, although their in vitro antifungal 
action fell within the serum blood levels reached by 
these drugs in man. Pinto (2003) observed that the 
C. albicans strains obtained from patients with HIv, 
cancer, diabetes and other diseases, also showed in 
vitro susceptibility to 5-fluorocytosine.
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